ADHD medication in childhood may lower risk of psychosis later in life
Analysis Summary
- Propaganda Score
- 0% (confidence: 95%)
- Summary
- A study published in JAMA Psychiatry found no evidence that ADHD medication methylphenidate increases long-term psychosis risk and suggested it may offer protective effects when used early. Researchers from University College Dublin and the University of Edinburgh analyzed health data from over 700,000 people, noting limitations in their analysis of amphetamines and adult ADHD cases.
Fact-Check Results
“The study provides one of the clearest indications to date that a widely used ADHD medication does not increase long-term psychosis risk - and may even offer some protection when used early in life.”
❓
INSUFFICIENT EVIDENCE
— No relevant evidence found in archive to verify or contradict the claim about ADHD medication and psychosis risk
“A major new study has found that commonly prescribed medication for attention deficit hyperactivity disorder (ADHD) in childhood may not only be safe in the long term, but could also lower the risk of developing serious psychotic disorders later in life.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm the long-term safety or risk reduction claims about ADHD medication
“The research, led by scientists at University College Dublin and the University of Edinburgh, challenges longstanding concerns that stimulant medications might increase the risk of conditions such as schizophrenia.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify the specific research claims about stimulant medications and schizophrenia risk
“ADHD is one of the most common mental disorders, affecting an estimated 8 percent of children and teenagers. Worldwide, around 366 million adults have ADHD, with symptoms including trouble focusing, restlessness, and impulsivity.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm ADHD prevalence statistics for children or adults
“No evidence of increased psychosis risk”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify findings about methylphenidate and psychosis risk
“The study, published in JAMA Psychiatry, analysed health data from nearly 700,000 people born in Finland, including close to 4,000 people diagnosed with ADHD.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm study details about Finnish health data analysis
“Researchers found no evidence that treatment with methylphenidate - the most commonly prescribed ADHD medication for children - increased the likelihood of developing psychotic disorders in adulthood.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify methylphenidate's impact on psychosis risk
“A number of studies have shown that a small but significant minority of children with ADHD go on to develop psychotic disorders – in our study about 6 percent did.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm ADHD psychosis development rates
“A possible protective effect in younger children”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify age-specific protective effects of methylphenidate
“The study also does not address the growing number of adults being diagnosed with ADHD.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm study limitations regarding adult ADHD diagnoses